UnitedHealth Group Incorporated (NYSE:UNH) was the recipient of unusually large options trading on Monday. Stock investors purchased 9,979 put options on the stock. This is an increase of 595% compared to the average volume of 1,435 put options.

Several brokerages have recently issued reports on UNH. UBS AG reaffirmed a “buy” rating and issued a $194.00 target price (up from $193.00) on shares of UnitedHealth Group in a report on Saturday, April 22nd. BidaskClub cut UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research note on Wednesday. Mizuho set a $235.00 price objective on UnitedHealth Group and gave the stock a “buy” rating in a research note on Tuesday. Barclays PLC boosted their price objective on UnitedHealth Group from $200.00 to $217.00 and gave the stock an “overweight” rating in a research note on Wednesday. Finally, Cowen and Company reissued a “buy” rating on shares of UnitedHealth Group in a research note on Friday, July 14th. One equities research analyst has rated the stock with a hold rating and twenty-five have assigned a buy rating to the company’s stock. UnitedHealth Group has a consensus rating of “Buy” and an average price target of $194.60.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction dated Wednesday, June 7th. The stock was sold at an average price of $182.64, for a total value of $913,200.00. Following the sale, the director now directly owns 75,735 shares of the company’s stock, valued at $13,832,240.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Gail R. Wilensky sold 5,540 shares of UnitedHealth Group stock in a transaction dated Friday, June 2nd. The stock was sold at an average price of $178.74, for a total value of $990,219.60. Following the completion of the sale, the director now directly owns 60,516 shares in the company, valued at $10,816,629.84. The disclosure for this sale can be found here. Insiders own 0.89% of the company’s stock.

Large investors have recently added to or reduced their stakes in the company. Silvercrest Asset Management Group LLC boosted its stake in shares of UnitedHealth Group by 3.6% in the fourth quarter. Silvercrest Asset Management Group LLC now owns 12,086 shares of the healthcare conglomerate’s stock worth $1,934,000 after buying an additional 424 shares during the period. William Blair Investment Management LLC boosted its stake in shares of UnitedHealth Group by 13.4% in the fourth quarter. William Blair Investment Management LLC now owns 697,694 shares of the healthcare conglomerate’s stock worth $111,659,000 after buying an additional 82,511 shares during the period. A.R.T. Advisors LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter worth $2,224,000. Roundview Capital LLC boosted its stake in shares of UnitedHealth Group by 4.8% in the fourth quarter. Roundview Capital LLC now owns 11,684 shares of the healthcare conglomerate’s stock worth $1,870,000 after buying an additional 540 shares during the period. Finally, Scotia Capital Inc. boosted its stake in shares of UnitedHealth Group by 12.7% in the fourth quarter. Scotia Capital Inc. now owns 48,283 shares of the healthcare conglomerate’s stock worth $7,732,000 after buying an additional 5,451 shares during the period. 86.21% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group (NYSE:UNH) opened at 189.19 on Thursday. The stock’s 50 day moving average price is $183.60 and its 200-day moving average price is $171.00. The firm has a market capitalization of $182.32 billion, a P/E ratio of 24.22 and a beta of 0.64. UnitedHealth Group has a 12 month low of $132.39 and a 12 month high of $189.41.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.38 by $0.08. The business had revenue of $50.05 billion during the quarter, compared to analysts’ expectations of $49.97 billion. UnitedHealth Group had a net margin of 4.13% and a return on equity of 21.42%. The company’s revenue for the quarter was up 7.7% on a year-over-year basis. During the same period in the previous year, the company earned $1.96 EPS. Equities analysts forecast that UnitedHealth Group will post $9.86 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 27th. Stockholders of record on Monday, June 19th were given a dividend of $0.75 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $0.63. This represents a $3.00 annualized dividend and a dividend yield of 1.59%. The ex-dividend date of this dividend was Thursday, June 15th. UnitedHealth Group’s payout ratio is 37.36%.

WARNING: “UnitedHealth Group Target of Unusually Large Options Trading (UNH)” was first published by American Banking News and is the property of of American Banking News. If you are viewing this piece on another publication, it was copied illegally and reposted in violation of U.S. and international trademark & copyright legislation. The original version of this piece can be read at https://www.americanbankingnews.com/2017/07/20/unitedhealth-group-target-of-unusually-large-options-trading-unh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.